NOWDiagnostics, Inc. raised $22.5 million in Series B funding led by DigitalDx Ventures with Labcorp Venture Fund and Kompass Kapital Management participating
NOWDiagnostics, Inc. (NOWDx) has secured $22.5 million in Series B financing. The oversubscribed funding round will be used to drive the commercialization of at-home diagnostic tests, continue developing new diagnostic innovations, expand the pipeline of tests, and support strategic hiring initiatives.
Who to call at NOWDiagnostics, Inc., and when
A new round usually means NOWDiagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
An alert the day NOWDiagnostics, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at NOWDiagnostics, Inc., from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
NOWDiagnostics, Inc.
Location
1200 Stewart Pl
Springdale, Arkansas, United States
About
NOWDiagnostics (NOWDx) develops and manufactures 'Touch to Test' over-the-counter and point of care diagnostic tests that yield results in minutes. It is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NOWDiagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SpringdaleManufacturingBiotechnologyHealthcareHealth CareMedical Device